PHRMAG

Committees

The PHRMAG Executive Committee (EC) comprises of experienced industry leaders that are committed to providing strategic counsel, and serve as mentors for PHMRAG working groups. The PHRMAG EC plays a crucial role in fostering collaboration, and driving our mission forward in the Gulf region.
Sameh El Fangary
Chairman

Cluster President, AstraZeneca
GCC & Pakistan

Ashraf Mallak
Vice Chairman

Managing Director GCC, MSD

Diederik Kok
EC Member & Treasurer

Head of GCC, Biogen

Ahmed Aboelfadl
EC Member

General Manager Gulf, Merck Serono

Shahad Mahdi
Secretary General

PHRMAG

Elhussein Abdellatif
EC Member

General Manager Gulf & Levant, AbbVie Biopharmaceuticals
GmbH

Roberta Marinelli
EC Member

President and General Manager, Meta Hub, Eli Lilly

Pedro Matos Rosa
EC Member
General Manager, Johnson & Johnson Innovative Medicines Gulf

Working Groups

The Working Groups at PHRMAG are dedicated to driving progress and excellence across geographies and in various key functional areas, These committees are strategically aligned with our mission and the needs of the healthcare ecosystems to help address important industry challenges, shape policies, and ensure compliance with ethical standards.
Compliance and Legal
Lead: Youssef Mourad (Roche)
Mentor: Sameh El Fangary (AstraZeneca)
Value and Access
Lead: Yomna Nowier (Novartis)
Mentor: Pedro Matos Rosa (Johnson & Johnson)
Qatar, Oman & Bahrain
Lead: Sally Berri
Mentor: Roberta Marinelli (Eli Lilly)
Regulation EDE
Lead: Ibrahim Aqel
Mentor: Diedrick Kok (Biogen)
Regulation DOH, DHA, MOHAP
Lead: Ghaleb Al Ahdab (Boehringer Ingelheim)
Mentor: Ashraf Mallak (MSD)
IP and Policy Working
Lead: Samia Kanawati
Mentor: Ahmed Abou Fadl (Merck)
Kuwait
Lead: Abdelrahman Elkhouly
Mentor: Elhussein Abdellatif
Communications
Lead: Joy Khoury (Novartis)